KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 73 filers reported holding KRONOS BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,314 | -84.8% | 10,489 | -83.1% | 0.00% | – |
| Q4 2022 | $100,677 | -52.7% | 62,146 | -2.2% | 0.00% | – |
| Q3 2022 | $213,000 | -12.3% | 63,569 | -4.4% | 0.00% | – |
| Q2 2022 | $243,000 | -41.6% | 66,506 | +15.7% | 0.00% | – |
| Q1 2022 | $416,000 | +123.7% | 57,483 | +320.0% | 0.00% | – |
| Q4 2021 | $186,000 | -35.9% | 13,688 | -1.2% | 0.00% | – |
| Q3 2021 | $290,000 | +3.9% | 13,859 | +18.5% | 0.00% | – |
| Q2 2021 | $279,000 | -96.1% | 11,700 | -95.2% | 0.00% | -100.0% |
| Q1 2021 | $7,177,000 | -36.4% | 245,203 | -35.1% | 0.00% | -33.3% |
| Q4 2020 | $11,283,000 | – | 377,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $3,428,989 | 3.75% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,609,469 | 0.39% |
| Acuitas Investments, LLC | 443,457 | $549,887 | 0.29% |
| CM Management, LLC | 135,000 | $167,400 | 0.15% |
| Privium Fund Management (UK) Ltd | 292,182 | $341,853 | 0.13% |
| Alphabet Inc. | 1,438,232 | $1,783,408 | 0.09% |
| Forefront Analytics, LLC | 134,998 | $167,400 | 0.08% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 1,665,797 | $2,044,488 | 0.04% |
| Artal Group S.A. | 842,954 | $1,045,263 | 0.03% |
| VESTIA PERSONAL WEALTH ADVISORS | 15,718 | $19,490 | 0.02% |